Biotricity Inc. financial data

Symbol
BTCY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
203 Redwood Parkway, Suite 600, Redwood City, CA
State of incorporation
NV
Fiscal year end
March 31
Former names
METASOLUTIONS, INC. (to 1/5/2016)
Latest financial report
10-Q/A - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 20.4 % -30%
Quick Ratio 8.36 % -39.9%
Debt-to-equity -112 % +9.34%
Return On Equity 34.3 % -42.5%
Return On Assets -188 % +19.4%
Operating Margin -35 % +56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24.8M shares +167%
Common Stock, Shares, Outstanding 24.4M shares +163%
Entity Public Float 16.3M USD -49.9%
Common Stock, Value, Issued 24.6K USD +161%
Weighted Average Number of Shares Outstanding, Basic 24.2M shares +170%
Weighted Average Number of Shares Outstanding, Diluted 24.2M shares +170%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 13.3M USD +14.1%
Cost of Revenue 3.41M USD -15%
Research and Development Expense 2.29M USD -10.7%
Operating Income (Loss) -4.64M USD +49.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.7M USD +26.9%
Net Income (Loss) Attributable to Parent -10.7M USD +26.9%
Earnings Per Share, Basic -1.09 USD/shares +51.1%
Earnings Per Share, Diluted -1.09 USD/shares +51.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 510K USD +499%
Accounts Receivable, after Allowance for Credit Loss, Current 1.24M USD -21.5%
Inventory, Net 1.57M USD -23.4%
Assets, Current 4.86M USD +23.6%
Property, Plant and Equipment, Net 11.1K USD -34.9%
Operating Lease, Right-of-Use Asset 919K USD -30.1%
Assets 5.99M USD +9.14%
Accrued Liabilities, Current 3.75M USD +29.7%
Liabilities, Current 21.1M USD +13.5%
Operating Lease, Liability, Noncurrent 539K USD -48.7%
Liabilities 35.8M USD +11.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 3.27K USD
Retained Earnings (Accumulated Deficit) -137M USD -11.6%
Stockholders' Equity Attributable to Parent -31.9M USD -15.1%
Liabilities and Equity 5.99M USD +9.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.49M USD +18.4%
Net Cash Provided by (Used in) Financing Activities 868K USD -34.7%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 24.4M shares +163%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 707K USD +173%
Deferred Tax Assets, Valuation Allowance 18.2M USD +18.1%
Operating Lease, Liability 1.05M USD -28%
Depreciation 1.49K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.1M USD +9.23%
Lessee, Operating Lease, Liability, to be Paid 1.72M USD 0%
Property, Plant and Equipment, Gross 29.8K USD 0%
Operating Lease, Liability, Current 512K USD +25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 565K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 600K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 667K USD +159%
Lessee, Operating Lease, Liability, to be Paid, Year Three 565K USD -5.82%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 565K USD
Additional Paid in Capital 105M USD +10%
Interest Expense 3.19M USD +12.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%